MTMR11

Across TCGA pan-cancer cohorts, MTMR11 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated MTMR11 data layer compared with 19 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MTMR11 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTMR11 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

HNSC, SCLC, and LUAD are the cancer types where MTMR11 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	All	0.234	0.606	.003	33	view →
SCLC	OS	Median	All	0.082	0.822	<.001	6	view →
LUAD	OS	Median	III,IV	0.068	0.680	<.001	6	view →
UCEC	DFS	Median	All	0.949	0.828	.034	4	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MTMR11–HNSC (DFS)

Open the HNSC breakdown →